Recombinant HAV VP4 Protein (aa 6-245) [His] (VAng-Lsx0174)
HAV VP4 (aa 6-245) [His], recombinant protein from E. coli.
Datasheet
Specifications
Source
Human
Target
Hepatitis A Virus
Type
Viral Antigens
Applications
ELISA, WB, SDS-PAGE, Immunogen, etc.
Formulation
Each vial contains 100 μg of lyophilized protein in PBS with 8M Urea.
Purity
> 95 % pure by SDS-PAGE.
Storage
Store at 2 °C to 8 °C short term, -20 °C long term.
Antigen Information
Introduction
The Hepatitis A virus (HAV), or Hepatovirus A, is a virus of the Picornaviridae family. It takes human and vertebrates as its natural hosts. HAV isolates all belong to a single serotype, seven genetic groups now have been defined, four for humans (genotype number: I-III, and VII) and three for simian (genotype number: IV-VI). Hepatitis A is an infectious disease of the liver caused by the hepatitis A virus. HAV achieves about 1.4 million worldwide symptomatic cases per year and is the cause of Hepatitis A (formerly known as infectious hepatitis, an acute infectious disease of the liver). It is usually spread by eating food or drinking water contaminated with infected feces.
Alternative Names
HAV; HAV Ag; HAV VP3; Hepatitis A Virus VP3; Hep A; Hepatitis A Virus protein; Picornaviridae; Hepatovirus
Related Product
All of our products can only be used for research purposes. These vaccine ingredients CANNOT be used directly on humans or animals.
